Palladyne AI vs Red Cat
PDYN and RCAT side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PDYN | RCAT |
|---|---|---|
| Size and price | ||
| Market cap | $152M | – |
| Share price | $3.09 | $3.80 |
| Change, 1 year | −54.4% | −55.6% |
| Change, 5 years | −93.8% | 59.7% |
| Beta (5Y) | 2.76 | 1.37 |
| Employees | 161 | – |
| StockData Score | ||
| Total score | 11 | – |
| Valuation score | 3 | – |
| Growth score | 2 | – |
| Performance score | 1 | – |
| Health score | 5 | – |
| Dividend score | 0 | – |
| Valuation | ||
| P/S | 7.8× | – |
| P/B | 2.0× | – |
| FCF yield | −25.4% | – |
| Fair value | $4.56 | – |
| Margin of safety | 32.2% | – |
| Growth | ||
| Revenue growth (TTM) | 350% | – |
| Revenue growth, 5Y average | −9.9% | – |
| Profitability | ||
| Gross margin | 34.7% | – |
| Operating margin | −246% | – |
| Net margin | −197% | – |
| FCF margin | −198% | – |
| Return on equity | −60.4% | – |
| Return on invested capital | −327% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Current ratio | 6.27 | – |
| Altman Z-score | −4.22 | – |
| Piotroski F-score | 3 | – |
| Dividends and buybacks | ||
| Buyback yield | −23.8% | – |
| Shareholder yield | −23.8% | – |
| Ownership | ||
| Held by institutions | 25.4% | 54.7% |
| Held by insiders | 33.7% | 8.8% |
| Insider net buying, 12 months | −$555K (better) | −$7.9M |
| Short interest, % of float | 19.6% | 27.9% |
Go deeper
- PDYN stock overview
- PDYN income statement
- PDYN valuation and score
- RCAT stock overview
- RCAT income statement
- RCAT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.